Phillips Wealth Planners’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$224K Buy
1,128
+27
+2% +$6.73K 0.17% 191
2025
Q4
$285K Sell
1,101
-118
-10% -$30.2K 0.23% 151
2025
Q3
$343K Buy
1,219
+100
+9% +$27.3K 0.28% 120
2025
Q2
$287K Sell
1,119
-9
-0.8% -$2.15K 0.26% 137
2025
Q1
$241K Buy
1,128
+2
+0.2% +$467 0.26% 146
2024
Q4
$263K Buy
1,126
+1
+0.1% +$241 0.26% 132
2024
Q3
$268K Buy
1,125
+32
+3% +$7.15K 0.26% 145
2024
Q2
$210K Sell
1,093
-66
-6% -$13.4K 0.22% 170
2024
Q1
$214K Buy
+1,159
New +$212K 0.25% 164

Other funds holding RMD

Phillips Wealth Planners's RMD Position: Q1 2026 in Review

Phillips Wealth Planners increased its ResMed (RMD) stake by 2.5% in Q1 2026, buying an estimated $6.73K and bringing the position to 1,128 shares worth $224K. The position accounts for 0.17% of the portfolio, ranked #191.

Phillips Wealth Planners first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $343K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Phillips Wealth Planners held 1,128 shares of ResMed worth $224K as of Q1 2026.
  • Phillips Wealth Planners bought 27 ResMed shares in Q1 2026, an estimated $6.73K.
  • ResMed made up 0.17% of Phillips Wealth Planners's portfolio in Q1 2026, its #191 holding.
  • Phillips Wealth Planners first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
  • Phillips Wealth Planners's ResMed position peaked at $343K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Phillips Wealth Planners's 13F filing for Q1 2026, filed 14 May 2026.